188 Publications (Page 1 of 8)
2021
Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease.
Farag, Sherif SFarag, Sherif SSchwartz, Jennifer ESchwartz, Jennifer EAbu Zaid, MohammadAbu Zaid, MohammadThakrar, Teresa CSchwartz, Jennifer ESchwartz, Jennifer EThakrar, Teresa CThakrar, Teresa CBlakley, Ann JThakrar, Teresa CBlakley, Ann JBlakley, Ann JBlakley, Ann JAbonour, RafatRobertson, Michael JRobertson, Michael JAbonour, RafatRobertson, Michael JRobertson, Michael JBroxmeyer, Hal EZhang, ShuhongBroxmeyer, Hal EZhang, ShuhongZhang, Shuhong and Zhang, Shuhong
The New England journal of medicine, vol. 384, (no. 1), pp. 11-19, January 7, 2021. | Journal Article
 
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma.
Hájek, RomanMinařík, JiříStraub, JanPour, LuděkJungova, AlexandraBerdeja, Jesus GBoccadoro, MarioBrozova, LucieSpencer, AndrewRhee, Frits vanVela-Ojeda, JorgeThompson, Michael AAbonour, RafatChari, AjaiCook, GordonCostello, Caitlin LDavies, Faith EHungria, Vania TmLee, Hans CLeleu, XavierPuig, NoemiRifkin, Robert MTerpos, EvangelosUsmani, Saad ZWeisel, Katja CZonder, Jeffrey ABařinová, MagdaKuhn, Matyᚊilar, JiříČápková, LenkaGalvez, KennyLu, JinElliott, JenniferStull, Dawn MarieRen, Kaili and Maisnar, Vladimír
Future oncology (London, England), March 26, 2021. | Journal Article
 
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
Davies, FaithDavies, FaithDavies, FaithRifkin, RobertRifkin, RobertRifkin, RobertCostello, CaitlinCostello, CaitlinCostello, CaitlinMorgan, GarethMorgan, GarethMorgan, GarethUsmani, SaadUsmani, SaadAbonour, RafatAbonour, RafatPalumbo, AntonioPalumbo, AntonioPalumbo, AntonioRomanus, DorothyRomanus, DorothyHajek, RomanHajek, RomanHajek, RomanTerpos, EvangelosTerpos, EvangelosCherepanov, DashaCherepanov, DashaStull, Dawn MarieStull, Dawn MStull, Dawn MarieHuang, HuiHuang, HuiHuang, HuiLeleu, XavierLeleu, XavierBerdeja, JesusBerdeja, JesusLee, Hans CLee, Hans CLee, Hans CWeisel, KatjaWeisel, KatjaThompson, MichaelThompson, MichaelThompson, MichaelBoccadoro, MarioBoccadoro, MarioZonder, JeffreyZonder, JeffreyZonder, JeffreyCook, GordonCook, GordonCook, GordonPuig, NoemiPuig, NoemiVela-Ojeda, JorgeVela-Ojeda, JorgeVela-Ojeda, JorgeFarrelly, EileenFarrelly, EileenFarrelly, EileenRaju, AdityaRaju, AdityaBlazer, MarloBlazer, MarloChari, Ajai and Chari, Ajai
Annals of hematology, May 10, 2021. | Journal Article
2020
A Prospective Phase II Clinical Trial of CD26/Dipeptidyl Peptidase (DPP)-IV Inhibition for Prevention of Acute Graft Versus Host Disease (aGVHD) Following Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation
Farag, Sherif SFarag, Sherif SFarag, Sherif SZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad AbuNelson, Robert PNelson, Robert PNelson, Robert PSchwartz, Jennifer ESchwartz, Jennifer ESchwartz, Jennifer EThakrar, Teresa CThakrar, Teresa CThakrar, Teresa CHuntley, CarolHuntley, CarolHuntley, CarolBlakley, Anne JBlakley, Anne JBlakley, Anne JAbonour, RafatAbonour, RafatAbonour, RafatRobertson, Michael JRobertson, Michael JRobertson, Michael JZhang, ShuhongZhang, Shuhong and Zhang, Shuhong
Biology of Blood and Marrow Transplantation, vol. 26, (no. 3), pp. S28, March 2020. | Journal Article
 
Connect MM Registry as a national reference for United States multiple myeloma patients
Ailawadhi, SikanderJagannath, SundarNarang, MohitRifkin, Robert MTerebelo, Howard RToomey, KathleenDurie, Brian G. MHardin, James WGasparetto, Cristina JWagner, LynneOmel, James LKumar, VivekYue, LihuaKitali, AmaniAgarwal, Amit and Abonour, Rafat
Cancer Medicine, vol. 9, (no. 1), pp. 42, January 2020. | Journal Article
 
High‐dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases
Kalra, MaitriKalra, MaitriKalra, MaitriKalra, MaitriAdra, NabilAdra, NabilAdra, NabilAdra, NabilHanna, NasserHanna, NasserHanna, NasserHanna, NasserAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence H and Einhorn, Lawrence H
Cancer, vol. 126, (no. 6), pp. 1202-1207, Mar 2020. | Journal Article
 
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials
Gavriatopoulou, MariaGavriatopoulou, MariaGavriatopoulou, MariaGavriatopoulou, MariaGavriatopoulou, MariaChari, AjaiChari, AjaiChari, AjaiChari, AjaiChen, ChristineChen, ChristineChen, ChristineChen, ChristineChen, ChristineBahlis, NizarBahlis, NizarBahlis, NizarBahlis, NizarVogl, Dan TVogl, Dan TVogl, Dan TVogl, Dan TVogl, Dan TJakubowiak, AndrzejJakubowiak, AndrzejJakubowiak, AndrzejJakubowiak, AndrzejDingli, DavidDingli, DavidDingli, DavidDingli, DavidDingli, DavidCornell, Robert FCornell, Robert FCornell, Robert FCornell, Robert FCornell, Robert FHofmeister, Craig CHofmeister, Craig CHofmeister, Craig CHofmeister, Craig CHofmeister, Craig CSiegel, DavidSiegel, DavidSiegel, DavidSiegel, DavidSiegel, DavidBerdeja, Jesus GBerdeja, Jesus GBerdeja, Jesus GBerdeja, Jesus GReece, DonnaReece, DonnaReece, DonnaReece, DonnaReece, DonnaWhite, DarrellWhite, DarrellWhite, DarrellWhite, DarrellWhite, DarrellLentzsch, SuzanneLentzsch, SuzanneLentzsch, SuzanneLentzsch, SuzanneLentzsch, SuzanneGasparetto, CristinaGasparetto, CristinaGasparetto, CristinaGasparetto, CristinaGasparetto, CristinaHuff, Carol AHuff, Carol AnnHuff, Carol AnnHuff, Carol AnnHuff, Carol AnnJagannath, SundarJagannath, SundarJagannath, SundarJagannath, SundarBaz, RachidBaz, RachidBaz, RachidBaz, RachidNooka, Ajay KNooka, Ajay KNooka, Ajay KNooka, Ajay KNooka, Ajay KRichter, JoshuaRichter, JoshuaRichter, JoshuaRichter, JoshuaRichter, JoshuaAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatParker, Terri LParker, Terri LParker, Terri LParker, Terri LParker, Terri LYee, Andrew JYee, Andrew JYee, Andrew JYee, Andrew JYee, Andrew JMoreau, PhilippeMoreau, PhilippeMoreau, PhilippeMoreau, PhilippeMoreau, PhilippeLonial, SagarLonial, SagarLonial, SagarLonial, SagarTuchman, SaschaTuchman, SaschaTuchman, SaschaTuchman, SaschaWeisel, Katja CWeisel, Katja CWeisel, Katja CWeisel, Katja CWeisel, Katja CMohty, MohamadMohty, MohamadMohty, MohamadMohty, MohamadChoquet, SylvainChoquet, SylvainChoquet, SylvainChoquet, SylvainUnger, T JUnger, T JUnger, T JUnger, T JUnger, T JLi, KaiLi, KaiLi, KaiLi, KaiLi, KaiChai, YiChai, YiChai, YiChai, YiChai, YiLi, LinglingLi, LinglingLi, LinglingLi, LinglingLi, LinglingShah, JatinShah, JatinShah, JatinShah, JatinShah, JatinShacham, SharonShacham, SharonShacham, SharonShacham, SharonShacham, SharonKauffman, Michael GKauffman, Michael GKauffman, Michael GKauffman, Michael GKauffman, Michael GDimopoulos, Meletios AthanasiosDimopoulos, Meletios AthanasiosDimopoulos, Meletios Athanasios and Dimopoulos, Meletios Athanasios
Leukemia, 2020-Feb-24. | Journal Article
 
Prognostic significance of rate of tumor marker (TM) decline during high-dose chemotherapy (HDCT) for relapsed germ cell tumors (rGCT)
Adra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, NabilAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamLiu, HaoLiu, HaoLiu, HaoLiu, HaoLiu, HaoHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, LawrenceEinhorn, LawrenceEinhorn, LawrenceEinhorn, Lawrence and Einhorn, Lawrence
Journal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 403, 2020-02-20. | Journal Article
 
Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell Tumors
Zhang, Kevin JuanZhang, Kevin JuanZhang, Kevin JuanZhang, Kevin JuanZhang, Kevin JuanHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad AbuAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HAdra, NabilAdra, NabilAdra, NabilAdra, Nabil and Adra, Nabil
Clinical Genitourinary Cancer, 2020-Feb-08. | Journal Article
 
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry
Jagannath, SundarRifkin, Robert MGasparetto, Cristina JToomey, KathleenDurie, Brian G.MHardin, James WTerebelo, Howard RWagner, LynneNarang, MohitAilawadhi, SikanderOmel, James LSrinivasan, ShankarHe, MiaUng, BrianKitali, AmaniFlick, E. DawnAgarwal, Amit and Abonour, Rafat
Clinical Lymphoma, Myeloma and Leukemia, vol. 20, (no. 5), pp. 276, May 2020. | Journal Article
2019
A Highly Robust Model for Predicting Outcome of Multiple Myeloma Patients By Inferring Patient-Specific Transcription Factor Activity
Dong, ChuanpengYu, Christina YJohnson, Travis SReiter, Jill LAbu Zaid, Mohammad IssamAbonour, RafatRoodman, G. DavidHuang, Kun and Liu, Yunlong
Blood, vol. 134, (no. Supplement_1), pp. 1785, 2019-11-13. | Journal Article
 
A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy
Weisel, KatjaHungria, VaniaLeleu, XavierLee, HansRifkin, RobertCostello, CaitlinAbonour, RafatChari, AjaiPuig, NoemiBerdeja, JesusCook, GordonThompson, Michael ABoccadoro, MarioTerpos, EvangelosZonder, Jeffrey AVela-Ojeda, JorgeDavies, Faithvan Rhee, FritsHajek, RomanSpencer, AndrewOmel, JimArmour, MiraStull, Dawn MarieCarlson, GaryElliott, JenniferCherepanov, DashaFerrari, RendaSkacel, TomasRen, Kaili and Usmani, Saad
Clinical Lymphoma, Myeloma and Leukemia, vol. 19, (no. 10), pp. e5, October 2019. | Journal Article
 
Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect® MM Registry
Wagner, Lynne IToomey, KathleenAilawadhi, SikanderJagannath, SundarGasparetto, CristinaDurie, Brian G.MNarang, MohitRifkin, Robert MTerebelo, Howard ROmel, James LHardin, James WLee, Hans CSrinivasan, ShankarLiu, LiangDhalla, MazaherCatamero, Donna and Abonour, Rafat
Blood, vol. 134, (no. Supplement_1), pp. 1843, 2019-11-13. | Journal Article
 
Closing the Efficacy and Effectiveness Gap: Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) in Routine Clinical Practice Remain Comparable to the Outcomes Reported in the Phase 3 Tourmaline-MM1 Study
Hajek, RomanMinarik, JiriStraub, JanPour, LudekJungova, AlexandraBerdeja, Jesus GBoccadoro, MarioBrožová, LucieSpencer, Andrewvan Rhee, FritsVela-Ojeda, JorgeThompson, Michael AAbonour, RafatChari, AjaiCook, GordonCostello, Caitlin LDavies, Faith EHungria, Vania T.MLee, Hans CLeleu, XavierPuig, NoemiRifkin, Robert MTerpos, EvangelosUsmani, Saad ZWeisel, Katja CZonder, Jeffrey ABařinová, MagdaKuhn, MatyášSilar, JiriCapkova, LenkaGalvez, KennyLu, JinSkacel, TomasElliott, JenniferDemers, BrittanyStull, Dawn MarieRen, Kaili and Maisnar, Vladimir
Blood, vol. 134, (no. Supplement_1), pp. 1845, 2019-11-13. | Journal Article
 
Development of a Novel Deep Transfer Learning Framework to Characterize Inter- and Intra-Tumor Heterogeneity in Myeloma Patients
Johnson, Travis SYu, Christina YDong, ChuanpengWang, TongxinAbu Zaid, Mohammad IssamAbonour, RafatRoodman, G. DavidLiu, Yunlong and Huang, Kun
Blood, vol. 134, (no. Supplement_1), pp. 3075, 2019-11-13. | Journal Article
 
Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry
Terebelo, Howard RAbonour, RafatGasparetto, Cristina JToomey, KathleenDurie, Brian G. MHardin, James WJagannath, SundarWagner, LynneNarang, MohitFlick, E. DawnSrinivasan, ShankarYue, LihuaKitali, AmaniAgarwal, Amit and Rifkin, Robert M
British Journal of Haematology, vol. 187, (no. 5), pp. 614, December 2019. | Journal Article
 
Effect of t(11;14) on outcomes of patients (pts) with newly diagnosed multiple myeloma (NDMM) in the connect MM registry
Gasparetto, CristinaJagannath, SundarRifkin, Robert MDurie, Brian GNarang, MohitTerebelo, Howard RToomey, KathleenHardin, James WWagner, Lynne IAilawadhi, SikanderOmel, JamesLee, Hans ChulheeSrinivasan, ShankarDhalla, MazaherCatamero, DonnaAgarwal, Amit and Abonour, Rafat
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 8032, 2019-05-20. | Journal Article
 
Effect of t(11;14) on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry
Gasparetto, Cristina JJagannath, SundarRifkin, RobertDurie, BrianNarang, MohitTerebelo, HowardToomey, KathleenHardin, JamesWagner, LynneAilawadhi, SikanderOmel, JimLee, HansSrinivasan, ShankarDhalla, MazaherCatamero, DonnaAgarwal, Amit and Abonour, Rafat
Clinical Lymphoma, Myeloma and Leukemia, vol. 19, (no. 10), pp. e75, October 2019. | Journal Article
 
Frequency of and Associations Amongst Baseline Cytogenetics in Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM Registry
Ailawadhi, SikanderGasparetto, Cristina JJagannath, SundarRifkin, RobertDurie, BrianNarang, MohitTerebelo, HowardToomey, KathleenHardin, JamesWagner, LynneOmel, JimLee, HansSrinivasan, ShankarHe, MiaDhalla, MazaherCatamero, DonnaBharadwaj, AnjaliAgarwal, Amit and Abonour, Rafat
Clinical Lymphoma, Myeloma and Leukemia, vol. 19, (no. 10), pp. e75, October 2019. | Journal Article
 
High-Dose Chemotherapy and Autologous Stem Cell Transplant.
Adra, NabilAdra, NabilAbonour, Rafat, MD and Abonour, Rafat
The Urologic clinics of North America, vol. 46, (no. 3), pp. 439-448, August 2019. | Journal Article
 
High-Dose Thiotepa-Cyclophosphamide Results in Superior Outcomes Compared with Total Body Irradiation-Cyclophosphamide , Advanced Chronic Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Hyder, MustafaHyder, MustafaHyder, MustafaHyder, MustafaAgrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavErvin, KirstenErvin, KirstenErvin, KirstenErvin, KirstenSchmidt, CaitlinSchmidt, CaitlinSchmidt, CaitlinSchmidt, CaitlinCox, ElizabethCox, ElizabethCox, ElizabethCox, ElizabethNelson, RobertNelson, RobertNelson, RobertNelson, RobertSchwartz, JenniferSchwartz, JenniferSchwartz, JenniferSchwartz, JenniferZaid, MohammadZaid, MohammadZaid, MohammadZaid, MohammadRobertson, MichaelRobertson, MichaelRobertson, MichaelRobertson, MichaelAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatBrinda, BryanBrinda, BryanBrinda, BryanBrinda, BryanGrove, MeaganGrove, MeaganGrove, MeaganGrove, MeaganGriffin, ShawnGriffin, ShawnGriffin, ShawnGriffin, ShawnThakrar, TeresaThakrar, TeresaThakrar, TeresaThakrar, TeresaFarag, SherifFarag, SherifFarag, Sherif and Farag, Sherif
Biology of Blood and Marrow Transplantation, vol. 25, (no. 3), pp. S192, 20190301. | Journal Article
 
Higher Sirolimus Levels between Days 11-20 after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Increase the Risk of Hepatic Sinusuoidal Obstruction Syndrome (SOS) after Non-Busulfan Myeloablative Conditioning
Agrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavRanganath, PraveenRanganath, PraveenRanganath, PraveenRanganath, PraveenErvin, Kirsten DErvin, Kirsten DErvin, Kirsten DErvin, Kirsten DSchmidt, Caitlin ASchmidt, Caitlin ASchmidt, Caitlin ASchmidt, Caitlin ACox, Elizabeth ACox, Elizabeth ACox, Elizabeth ACox, Elizabeth ANelson, Robert PNelson, Robert PNelson, Robert PNelson, Robert PSchwartz, Jennifer ESchwartz, Jennifer ESchwartz, Jennifer ESchwartz, Jennifer EZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad AbuAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatRobertson, Michael JRobertson, Michael JRobertson, Michael JRobertson, Michael JBrinda, Bryan JBrinda, Bryan JBrinda, Bryan JBrinda, Bryan JGriffin, Shawn PGriffin, Shawn PGriffin, Shawn PGriffin, Shawn PThakrar, Teresa CThakrar, Teresa CThakrar, Teresa CThakrar, Teresa CFarag, Sherif SFarag, Sherif SFarag, Sherif S and Farag, Sherif S
Biology of Blood and Marrow Transplantation, vol. 25, (no. 3), pp. S144, March 2019. | Journal Article
 
Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host Disease
Agrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavAgrawal, VaibhavGriffin, Shawn PGriffin, Shawn PGriffin, Shawn PGriffin, Shawn PKoch, LindseyKoch, LindseyKoch, LindseyKoch, LindseyThakrar, Teresa CThakrar, Teresa CThakrar, Teresa CThakrar, Teresa CErvin, Kirsten DErvin, Kirsten DErvin, Kirsten DErvin, Kirsten DSchmidt, Caitlin ASchmidt, Caitlin ASchmidt, Caitlin ASchmidt, Caitlin ACox, Elizabeth ACox, Elizabeth ACox, Elizabeth ACox, Elizabeth ASchwartz, Jennifer ESchwartz, Jennifer ESchwartz, Jennifer ESchwartz, Jennifer EAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatRobertson, Michael JRobertson, Michael JRobertson, Michael JRobertson, Michael JBrinda, Bryan JBrinda, Bryan JBrinda, Bryan JBrinda, Bryan JNelson, Robert PNelson, Robert PNelson, Robert PNelson, Robert PFarag, Sherif SFarag, Sherif SFarag, Sherif SFarag, Sherif SZaid, Mohammad AbuZaid, Mohammad AbuZaid, Mohammad Abu and Zaid, Mohammad Abu
Biology of Blood and Marrow Transplantation, vol. 25, (no. 3), pp. S250, March 2019. | Journal Article
 
Prognostic value of serum tumor marker (STM) rate of decline during high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT) for relapsed germ-cell tumors (rGCT)
Adra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, NabilAdra, NabilAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KAlthouse, Sandra KLiu, HaoLiu, HaoLiu, HaoLiu, HaoLiu, HaoLiu, HaoLiu, HaoAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamAbu Zaid, Mohammad IssamCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintCary, ClintMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AMasterson, Timothy AFoster, RichardFoster, RichardFoster, RichardFoster, RichardFoster, RichardFoster, RichardFoster, RichardAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineAlbany, CostantineHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HHanna, Nasser HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence HEinhorn, Lawrence H and Einhorn, Lawrence H
Journal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e16044, 2019-05-20. | Journal Article
 
Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational Study
Hungria, Vania T.MLee, Hans CAbonour, RafatRifkin, Robert MTerpos, EvangelosLeleu, XavierCostello, Caitlin Lvan Rhee, FritsWeisel, Katja CPuig, NoemiBerdeja, Jesus GCook, GordonUsmani, Saad ZThompson, Michael ABoccadoro, MarioZonder, Jeffrey ASpencer, AndrewHajek, RomanFanning, Suzanne RBoyd, KevinOmel, JimArmour, MiraMorgan, Kathryn EPatel, Ronak SCarlson, Gary LFerrari, Renda HStull, Dawn MarieRen, KailiCherepanov, DashaPottala, James V and Chari, Ajai
Blood, vol. 134, (no. Supplement_1), pp. 1887, 2019-11-13. | Journal Article